(CRBP) |
| 0 (0%) 08-01 20:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 9.88 |
| Resistance 1: | 9.24 |
| Pivot price: | 9.01 |
| Support 1: | 8.21 |
| Support 2: | 6.83 |
| 52w High: | |
| 52w Low: |
| EPS | -5.740 |
| Book Value | 7.120 |
| PEG Ratio | 0.00 |
| Gross Profit | -4.008 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -39.5 |
| Return on Equity (ttm) | -66.7 |
Fri, 31 Jul 2026
Corbus Pharmaceuticals Holdings Inc expected to post a loss of $1.26 a share - Earnings Preview - TradingView
Thu, 30 Jul 2026
CRBP|Corbus Pharmaceuticals Holdings Inc|Price:8.930|Chg%:-0.155 - TradingKey
Wed, 29 Jul 2026
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Tue, 28 Jul 2026
Corbus Pharmaceuticals (CRBP) Gains FDA Nod for Pivotal CRB-701 - GuruFocus
Mon, 27 Jul 2026
BlackRock, Inc. (CRBP) discloses 5.9% beneficial ownership in Corbus Pharmaceuticals - Stock Titan
Thu, 23 Jul 2026
(CRBP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |